BSX Q4 2021 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.1B+15.5% YoY

Gross Profit

$1.9B62.1% margin

Operating Income

$457M14.6% margin

Net Income

$94M3.0% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

$478M

Free Cash Flow

$212M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$32.2B

Total Liabilities

$15.6B

Stockholders' Equity

$16.6B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.1B	$2.7B	+15.5%
Gross Profit	$1.9B	$1.5B	+29.3%
Operating Income	$457M	$174M	+162.6%
Net Income	$94M	$152M	-38.2%

Revenue Segments

Cardiovascular

$1.3B41%

MedSurg

$999M32%

Cardiac Rhythm Management

$858M27%

Geographic Segments

UNITED STATES

$1.8B58%

Non-US

$1.3B42%